Other: HIV/AIDS & STBBI Clinical Trials Research Network – Phase 1
Canadian Institutes of Health Research (CIHR)
In alignment with the priorities of the CIHR HIV/AIDS and STBBI Research Initiative Strategic Plan: 2022-2027, and the Government of Canada's Pan-Canadian STBBI Framework for Action, the purpose of the CIHR Pan-Canadian Network for HIV/AIDS and STBBI Clinical Trials Research funding opportunity is to support a single, nationally-coordinated, interdisciplinary clinical trials research network (the Network) for addressing STBBI, including but not limited to HIV/AIDS, hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis and human papilloma virus (HPV).
There is one grant available valued at $25,000,000 for five years.
Anticipated Notice of Decision: June 20, 2024
Funding Start Date: June 1, 2024
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Registration |
| 25-Oct-2023 |
Application | 09-Feb-2024 4:30 pm CST | 21-Feb-2024 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.